
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Diabetes & Obesity Series
Subscribe to RSS feed of this series
Sandra Chase
VP Operations
HCG
Ms. Chase offers sites, CROs, and sponsors ways to improve communication and education so that diabetes subjects will stay in the trial.
Others in the Series
Associations and Societies
Clinical Trials
Articles, Multimedia
Associations and Societies
Clinical Trials






